#Drugdiscovery
Dr. Aaron Sato, the Chief Scientist Officer of Twist Bioscience, recently visited Taiwan to give a lecture on DNA variant libraries and AI-assisted antibody discovery. The seminar was held at the National Biotechnology Research Park in partnership with Abreal Biotech, the official distributor of Twist Bioscience in Taiwan.
Dr. Aaron Sato explained how the Twist synthetic platform ensures that clients can receive the exact library they want with no compromises, and artificial intelligence (#AI) machine-learning techniques can assist in discovering antibody sequences through successive panning rounds and next-generation sequencing (#NGS).
Jin-You Hu, General Manager of Abreal Biotech, believes that combining AI machine learning with synthetic DNA library technology in biopharmaceutical development is a challenging yet promising task. This lecture reflects Twist and Abreal Biotech's commitment to providing more efficient and accurate solutions to Taiwan's drug developers.
Learn more: https://lnkd.in/gAy27WDs
Stay tuned for more cutting-edge updates and news on #pharma and #biotech from #Globalbio!
Dr. Aaron Sato visited Taiwan to give a lecture on AI-assisted antibody discovery
撰文GlobalBio & Investment
日期2024-04-30
![](/upload/article/_images/1712150544294.jpg)
Dr. Aaron Sato visited Taiwan to give a lecture on DNA variant libraries and AI-assisted antibody discovery
下一篇